BOYER ANDREW S

CIK 00012395462 companiesMORRISTOWN, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001239546

Recent Transactions

50 trades

Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Stock Option
2025-08-20−175,000→ 97,480 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-08-20$2.75/sh+175,000→ 431,670 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-08-20$9.38/sh−279,244→ 152,426 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-08-12$9.05/sh−33,436→ 256,670 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-05$8.89/sh−125,000→ 290,106 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-04−38,194→ 114,582 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-04$8.84/sh−19,537→ 415,106 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-04+38,194→ 434,643 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03$8.76/sh−25,419→ 319,753 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03+157,005→ 476,758 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-03−39,251→ 39,252 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03$8.76/sh−20,077→ 295,478 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2025-03-03+194,064→ 194,064 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03+39,251→ 315,555 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-03+97,032→ 97,033 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-03−49,694→ 99,389 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2025-03-03−157,005→ 0 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03$8.76/sh−80,309→ 396,449 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03+49,694→ 345,172 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-01$8.67/sh−11,737→ 276,304 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-01−31,371→ 0 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-01+31,371→ 288,041 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-08-15$7.85/sh−40,225→ 256,670 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-08-14$7.81/sh−22,486→ 296,895 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2024-03-04+305,556→ 305,556 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-03-04+152,778→ 152,778 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-03+49,694→ 344,278 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-03$5.47/sh−19,665→ 294,584 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-03+39,251→ 314,249 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-03-03−49,694→ 149,083 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-03-03−39,251→ 78,503 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-03$5.47/sh−24,897→ 319,381 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-01$5.47/sh−16,219→ 274,998 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-01+31,371→ 291,217 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-03-01−31,371→ 31,371 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-02-27+31,663→ 276,402 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-02-27$5.71/sh−16,556→ 259,846 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-02-27−31,663→ 0 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2023-08-11$4.13/sh−29,302→ 244,739 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2023-06-30+23,095→ 285,612 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2023-06-30$3.10/sh−11,571→ 274,041 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2023-06-30−23,095→ 0 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2023-03-03+198,777→ 198,777 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2023-03-03+39,251→ 282,202 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2023-03-03$1.92/sh−19,685→ 262,517 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2023-03-03−39,251→ 117,754 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2023-03-03+397,554→ 397,554 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2023-03-01$2.09/sh−16,121→ 242,951 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2023-03-01+31,371→ 259,072 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2023-03-01$2.09/sh−6,846→ 227,701 total

Companies

Recent Filings

Address

C/O WATSON PHARMA, INC. 360 MOUNT KEMBLE AVENUE

MORRISTOWN, NJ, 07960

View on SEC.gov